Revision of the Synthesis and Pharmacological Activity of a Reported Translation Inhibitor


Cite item

Full Text

Abstract

4EGI-1 is the prototype of a novel class of anticancer agents targeting translation. Patented drug-like analogue 1 was synthesized and examined for inhibition of translation and cytotoxicity in cancer cells. Unexpectedly, 1 was found inactive in both assays.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bentham Science Publishers